A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...
On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...
Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...
Zacks Investment Research on MSN
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
The colonies of Escherichia coli sitting in this petri dish become pathogenic when they carry Shiga toxin genes. Credit: Shutterstock “We’re essentially converting a pathogenic strain into a ...
Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer. As researchers have learned more and more about the cancer-immune system interplay, ...
That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene editing that they believe may be safer and more efficient than the common ...
Like the find-and-replace feature of a word processor, CRISPR-based engineering allows scientists to quickly and efficiently edit DNA sequences with base pair precision. Lauded as the great ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback